Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate N515DRAFT_1432 N515DRAFT_1432 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::Q83E11 (438 letters) >FitnessBrowser__Dyella79:N515DRAFT_1432 Length = 434 Score = 461 bits (1185), Expect = e-134 Identities = 227/429 (52%), Positives = 313/429 (72%), Gaps = 1/429 (0%) Query: 1 MDYQTIPSQGLSGEICVPGDKSISHRAVLLAAIAEGQTQVDGFLMGADNLAMVSALQQMG 60 +D+ + P++ L G + VPGDKS+SHR+++L+A+AEG++ + GFL G D A + LQ++G Sbjct: 4 LDWLSQPARALHGNVRVPGDKSVSHRSMMLSALAEGRSHIRGFLEGEDTRATAAVLQKLG 63 Query: 61 ASIQVIEDENILVVEGVGMTGLQAPPEALDCGNSGTAIRLLSGLLAGQPFNTVLTGDSSL 120 I+ E +V+GVG+ GL+ +ALDCGN+GT +RLL+GLLAGQ F++ L GD SL Sbjct: 64 VRIET-PSEGERIVDGVGLHGLRGTAQALDCGNAGTGMRLLAGLLAGQAFDSTLVGDESL 122 Query: 121 QRRPMKRIIDPLTLMGAKIDSTGNVPPLKIYGNPRLTGIHYQLPMASAQVKSCLLLAGLY 180 +RPM+R+ +PL MGA+ID+ +PPL+++G L GI Y LP+ASAQVKS LLLAGLY Sbjct: 123 SKRPMRRVTEPLAAMGARIDTQDGLPPLRVHGGQPLKGIRYTLPVASAQVKSALLLAGLY 182 Query: 181 ARGKTCITEPAPSRDHTERLLKHFHYTLQKDKQSICVSGGGKLKANDISIPGDISSAAFF 240 A+G+T + EP P+RD+TER+L F + ++ + +SGG +L+A D+ +P D SSAAFF Sbjct: 183 AQGETEVIEPHPTRDYTERMLAAFGWPIEFEPGRARLSGGHRLRATDVEVPADFSSAAFF 242 Query: 241 IVAATITPGSAIRLCRVGVNPTRLGVINLLKMMGADIEVTHYTEKNEEPTADITVRHARL 300 +VA +I PG+ +RL VG+NP R G++ L++MGADI V + E EP D+ VRHA L Sbjct: 243 LVAGSIVPGAELRLPAVGLNPRRTGLLQALRLMGADIAVENQRESGGEPVGDLIVRHAPL 302 Query: 301 KGIDIPPDQVPLTIDEFPVLLIAAAVAQGKTVLRDAAELRVKETDRIAAMVDGLQKLGIA 360 G+++P VP IDEFP L IAAAVAQG+TV+R AAELRVKE+DRIA M G++ +G Sbjct: 303 HGVELPEALVPDMIDEFPALFIAAAVAQGRTVVRGAAELRVKESDRIATMAAGMKAIGAR 362 Query: 361 AESLPDGVIIQGGTLEGGEVNSYDDHRIAMAFAVAGTLAKGPVRIRNCDNVKTSFPNFVE 420 E PDG II+GG L GGEV+S+ DHRIAM+FAVAG +A+ P+RI +C NV TSFP F+E Sbjct: 363 IEETPDGAIIEGGALRGGEVDSHGDHRIAMSFAVAGLVAQEPIRIADCANVATSFPGFME 422 Query: 421 LANEVGMNV 429 LAN G ++ Sbjct: 423 LANGCGFDL 431 Lambda K H 0.318 0.137 0.392 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 625 Number of extensions: 31 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 438 Length of database: 434 Length adjustment: 32 Effective length of query: 406 Effective length of database: 402 Effective search space: 163212 Effective search space used: 163212 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate N515DRAFT_1432 N515DRAFT_1432 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.2048470.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 4.8e-128 413.4 0.0 5.9e-128 413.1 0.0 1.0 1 FitnessBrowser__Dyella79:N515DRAFT_1432 Domain annotation for each sequence (and alignments): >> FitnessBrowser__Dyella79:N515DRAFT_1432 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 413.1 0.0 5.9e-128 5.9e-128 1 411 [. 16 426 .. 16 429 .. 0.95 Alignments for each domain: == domain 1 score: 413.1 bits; conditional E-value: 5.9e-128 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakveee.keelviegvgg..lk 67 g++++pg+KS+shR+++l+aLaeg++ ++++L++eDt+at +l+klG+++e ++e +++gvg l+ FitnessBrowser__Dyella79:N515DRAFT_1432 16 GNVRVPGDKSVSHRSMMLSALAEGRSHIRGFLEGEDTRATAAVLQKLGVRIETPsEGERIVDGVGLhgLR 85 789*************************************************5549999****9986677 PP TIGR01356 68 epeaeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlais 137 ++ld+gn+Gt +Rll g+la ++++++l gdesl+kRP++r++e+L ++ga+i+ ++ g +Pl+++ FitnessBrowser__Dyella79:N515DRAFT_1432 86 GTAQALDCGNAGTGMRLLAGLLAGQAFDSTLVGDESLSKRPMRRVTEPLAAMGARIDTQD--GLPPLRVH 153 777******************************************************876..89****** PP TIGR01356 138 gplkg.givelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederk 206 g++++ gi + + aS+Q+ksallla+ l a++++ v+e+ +r+y+e++L+ ++ +e e + + FitnessBrowser__Dyella79:N515DRAFT_1432 154 GGQPLkGIRYTLPVASAQVKSALLLAG---LYAQGETEVIEPHPTRDYTERMLAAFGWP---IEFEPG-R 216 **9999*********************...77789999999***********9988766...888877.8 PP TIGR01356 207 ivvkggqkykqkevevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeq 275 ++ gg+ + ++vev++D+SsAaffl+a+ i ++ e+++ +g n+ +++ +++ L+ mGad+ ve+q FitnessBrowser__Dyella79:N515DRAFT_1432 217 ARLSGGHRLRATDVEVPADFSSAAFFLVAGSIVPGaELRLPAVGLNPRRTG--LLQALRLMGADIAVENQ 284 8999999988889**********************9***************..888************** PP TIGR01356 276 r........dvevegasklkgvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaia 336 r d++v++ l+gv+ ++ v+++iDe+p+l ++aa+A+g t++++++elRvkEsdRia +a FitnessBrowser__Dyella79:N515DRAFT_1432 285 ResggepvgDLIVRH-APLHGVELpEALVPDMIDEFPALFIAAAVAQGRTVVRGAAELRVKESDRIATMA 353 **************5.68******99******************************************** PP TIGR01356 337 eeLeklGveveeledgllieGkkkelkgavvdtydDHRiamalavlglaaegeveiedaecvaksfPeFf 406 + ++++G+++ee++dg +ieG+ l+g++vd+++DHRiam++av+gl+a+++++i d + va+sfP F+ FitnessBrowser__Dyella79:N515DRAFT_1432 354 AGMKAIGARIEETPDGAIIEGG--ALRGGEVDSHGDHRIAMSFAVAGLVAQEPIRIADCANVATSFPGFM 421 **********************..6********************************************* PP TIGR01356 407 evleq 411 e+++ FitnessBrowser__Dyella79:N515DRAFT_1432 422 ELANG 426 99876 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (434 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 15.76 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory